These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 2785142)

  • 1. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
    Larsson A; Jonsson L; Sjöquist J
    J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
    Garred P; Michaelsen TE; Aase A; Mollnes TE
    J Immunol; 1990 Jan; 144(1):198-203. PubMed ID: 2295791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia.
    Agnello V; Mitamura T
    Clin Immunol Immunopathol; 1987 Mar; 42(3):338-43. PubMed ID: 3493866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of complement component C5 to model immune complexes and the use of anti-C5 antibodies for determination of C5-containing circulating immune complexes.
    Larsson A; Sjöquist J
    J Clin Lab Immunol; 1989 Jan; 28(1):5-9. PubMed ID: 2724329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
    Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
    J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum complement components in patients with trachoma.
    Sen DK; Sarin GS; Hiranandani M; Baveja UK
    Br J Ophthalmol; 1985 Sep; 69(9):707-10. PubMed ID: 3876110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement components, C1 activation and disease activity in SLE.
    Sturfelt G; Sjöholm AG; Svensson B
    Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
    Antes U; Heinz HP; Loos M
    Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.
    Uwatoko S; Mannik M
    J Clin Invest; 1988 Sep; 82(3):816-24. PubMed ID: 3262124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis.
    Roberts JL; Wyatt RJ; Schwartz MM; Lewis EJ
    Clin Immunol Immunopathol; 1983 Nov; 29(2):223-41. PubMed ID: 6605223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ELISA for the evaluation of the classical pathway of complement.
    Zwirner J; Wittig A; Kremmer E; Götze O
    J Immunol Methods; 1998 Feb; 211(1-2):183-90. PubMed ID: 9617842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA.
    Stanilova SA; Slavov ES
    J Immunol Methods; 2001 Jul; 253(1-2):13-21. PubMed ID: 11384665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial clustering of non-nuclear autoantibodies and C3 and C4 complement components in systemic lupus erythematosus.
    Hunnangkul S; Nitsch D; Rhodes B; Chadha S; Roberton CA; Pessôa-Lopes P; Norsworthy PJ; Fernando MM; Charles P; Mackworth-Young C; Isenberg DA; Whittaker JC; Vyse TJ
    Arthritis Rheum; 2008 Apr; 58(4):1116-24. PubMed ID: 18383369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.